English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17933/22952 (78%)
Visitors : 7286981      Online Users : 493
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/20454


    Title: Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway
    Authors: Chuang, H.-Y.
    Lee, Y.-P.
    Lin, W.-C.
    Lin, Y.-H.
    Hwang, J.-J.
    Keywords: Fatty Acid Synthetase Complex;Neoplasms;Acid synthase
    Date: 2019-12
    Issue Date: 2019-11-14T09:20:02Z (UTC)
    ISSN: 2045-2322
    Abstract: Elevated fatty acid synthase (FASN) has been reported in both androgen-dependent and -independent prostate cancers. Conventional treatment for prostate cancer is radiotherapy (RT); however, the following radiation-induced radioresistance often causes treatment failure. Upstream proteins of FASN such as Akt and NF-κB are found increased in the radioresistant prostate cancer cells. Nevertheless, whether inhibition of FASN could improve RT outcomes and reverse radiosensitivity of prostate cancer cells is still unknown. Here, we hypothesised that orlistat, a FASN inhibitor, could improve RT outcomes in prostate cancer. Orlistat treatment significantly reduced the S phase population in both androgen-dependent and -independent prostate cancer cells. Combination of orlistat and RT significantly decreased NF-κB activity and related downstream proteins in both prostate cancer cells. Combination effect of orlistat and RT was further investigated in both LNCaP and PC3 tumour-bearing mice. Combination treatment showed the best tumour inhibition compared to that of orlistat alone or RT alone. These results suggest that prostate cancer treated by conventional RT could be improved by orlistat via inhibition of FASN. © 2019, The Author(s).
    URI: https://ir.csmu.edu.tw:8080/ir/handle/310902500/20454
    Relation: Scientific Reports, Volume 9, Issue 1, 1 December 2019, NO.13284
    Appears in Collections:[附設醫院] 期刊論文

    Files in This Item:

    File Description SizeFormat
    Fatty-Acid-Inhibition-Sensitizes-AndrogenDependent-and-Independent-Prostate-Cancer-to-Radiotherapy-via-FASNNFB-Pathway2019Scientific-Reports.pdf1655KbAdobe PDF179View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback